nivolumab,tegafur,oxaliplatin,oteracil,gimeracil,capecitabine
ono pharma,nordic group,otsuka,bms
[]
3. #attraction5 stage iiia-c, d2 resection, gc/gejc followed by adj chemo + placebo vs nivo - asian pt population (japan, korea, china, taiwan)
- negative for rfs (3yr rfs 68.4% vs 65.3%, p=0.4363)
- outcomes in cps+ and msi-h pending #gism #gastriccancer #asco23 4/7 
Practice changing 🗣 for community oncologists: w/ Rohit Gosain @UPMCHillmanCC & Rahul Gosain @WilmotCancer. Views are our own. COI: https://t.co/cJOjp0RvQE